Recherche
Résultats 1-10 de 46
-
Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT.
Bone Marrow Transplantation, 02-11-2021Article dans une revue scientifiquetexte intégral -
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplantation, 07-05-2023Article dans une revue scientifiquetexte intégral -
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, 28-03-2022, 56, 1047–1055Article dans une revue scientifique -
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Bone Marrow Transplantation, 09-07-2023Article dans une revue scientifique -
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype.
Bone Marrow Transplantation, 15-12-2023Article dans une revue scientifique -
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.
Bone Marrow Transplantation, 24-11-2023Article dans une revue scientifique -
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplantation, 13-04-2023Article dans une revue scientifique -
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.
Bone Marrow Transplantation, 18-02-2022, 57, 633–640Article dans une revue scientifiquetexte intégral -
Comparable outcomes of haploidentical transplant with tbf conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia
Bone Marrow Transplantation, 03-2021, 56, 622–634Article dans une revue scientifique -
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.
Bone Marrow Transplantation, 09-09-2023Article dans une revue scientifique